These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22313284)

  • 1. Cyril Clarke and the prevention of rhesus haemolytic disease of the newborn.
    Weatherall DJ
    Br J Haematol; 2012 Apr; 157(1):41-6. PubMed ID: 22313284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sir Cyril Astley Clark, C.B.E., 22 August 1907 - 21 November 2000.
    Weatherall D
    Biogr Mem Fellows R Soc; 2002; 48():71-85. PubMed ID: 13678068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The history of rhesus prophylaxis with anti-D.
    Wegmann A; Glück R
    Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rhesus prophylaxis--history and current status].
    Behrens O; Lellé RJ
    Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing rhesus babies: the Liverpool research and follow up.
    Clarke CA
    Arch Dis Child; 1989 Dec; 64(12):1734-40. PubMed ID: 2516436
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemolytic disease of the newborn: the new NICE guidelines.
    Thompson J
    J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classic pages in obstetrics and gynecology. Experimental studies on the prevention of Rh haemolytic disease: Ronald Finn, Cyril Astley Clarke, William Thomas Atkin Donohoe, Richard Bonar McConnell, Philip Macdonald Sheppard, Dermot Lehane, and William Kulke.
    Longo LD
    Am J Obstet Gynecol; 1977 Mar; 127(5):537. PubMed ID: 402076
    [No Abstract]   [Full Text] [Related]  

  • 8. Jack Bowman: Winnipeg's contributions to the treatment and prevention of Rhesus hemolytic disease of the newborn.
    Warren P; Jamieson JC
    Transfus Med Rev; 2010 Jan; 24(1):68-76. PubMed ID: 19962577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of fetomaternal anti-rhesus-D allo-immunization: methods used and topics discussed].
    Carbonne B; Goffinet F; Marpeau L
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S85-1S86. PubMed ID: 16495832
    [No Abstract]   [Full Text] [Related]  

  • 11. Decline in deaths from rhesus haemolytic disease of the newborn.
    Clarke C; Hussey RM
    J R Coll Physicians Lond; 1994; 28(4):310-1. PubMed ID: 7965968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention and management of haemolytic disease of the newborn.
    Contreras M; de Silva M
    J R Soc Med; 1994 May; 87(5):256-8. PubMed ID: 8207718
    [No Abstract]   [Full Text] [Related]  

  • 13. Rhesus immunization: new perspectives in maternal-fetal medicine.
    Stangenberg M; Selbing A; Lingman G; Westgren M
    Obstet Gynecol Surv; 1991 Apr; 46(4):189-95. PubMed ID: 1902926
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is rhesus prophylaxis indicated also with positive antibodies?].
    Behrens O
    Z Geburtshilfe Neonatol; 1996; 200(6):246. PubMed ID: 9081755
    [No Abstract]   [Full Text] [Related]  

  • 15. Economics of anti-rhesus prophylaxis in an African population.
    Verkuyl DA
    Cent Afr J Med; 1987 Feb; 33(2):32-7. PubMed ID: 3121186
    [No Abstract]   [Full Text] [Related]  

  • 16. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental studies on the prevention of Rh haemolytic disease.
    FINN R; CLARKE CA; DONOHOE WT; McCONNELL RB; SHEPPARD PM; LEHANE D; KULKE W
    Br Med J; 1961 May; 1(5238):1486-90. PubMed ID: 13699661
    [No Abstract]   [Full Text] [Related]  

  • 18. [15 years of Rh-immunization prevention program].
    Eklund J; Nevanlinna HR
    Katilolehti; 1984; 89(8):284-7. PubMed ID: 6441856
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma exchange in the management of severe rhesus haemolytic disease.
    Halligan A; McGuinness EP
    Ir Med J; 1990 Sep; 83(3):107-8. PubMed ID: 2121660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.